236 related articles for article (PubMed ID: 29508305)
1. Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.
Berger JR; Malik V; Lacey S; Brunetta P; Lehane PB
J Neurovirol; 2018 Jun; 24(3):323-331. PubMed ID: 29508305
[TBL] [Abstract][Full Text] [Related]
2. Rituximab utilization for approved and off-label nononcology indications and patients' experiences with the Patient Alert Card.
Sarsour K; Beckley-Kartey S; Melega S; Odueyungbo A; Kirchner P; Khalife N; Bangs J
Pharmacol Res Perspect; 2020 Feb; 8(1):e00555. PubMed ID: 31911839
[TBL] [Abstract][Full Text] [Related]
3. Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics.
Verheyen J; Maizus K; Feist E; Tolman Z; Knops E; Saech J; Spengler L; Waterboer T; Burmester GR; Pawlita M; Pfister H; Rubbert-Roth A
Med Microbiol Immunol; 2015 Oct; 204(5):613-8. PubMed ID: 25678083
[TBL] [Abstract][Full Text] [Related]
4. Progressive multifocal leukoencephalopathy in autoimmune diseases.
Palazzo E; Yahia SA
Joint Bone Spine; 2012 Jul; 79(4):351-5. PubMed ID: 22281228
[TBL] [Abstract][Full Text] [Related]
5. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis.
Fleischmann RM
Arthritis Rheum; 2009 Nov; 60(11):3225-8. PubMed ID: 19877057
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced progressive multifocal leukoencephalopathy: Lessons learned from contrasting natalizumab and rituximab.
Vermeer NS; Straus SM; Mantel-Teeuwisse AK; Hidalgo-Simon A; Egberts AC; Leufkens HG; De Bruin ML
Clin Pharmacol Ther; 2015 Nov; 98(5):542-50. PubMed ID: 26347128
[TBL] [Abstract][Full Text] [Related]
7. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis.
Clifford DB; Ances B; Costello C; Rosen-Schmidt S; Andersson M; Parks D; Perry A; Yerra R; Schmidt R; Alvarez E; Tyler KL
Arch Neurol; 2011 Sep; 68(9):1156-64. PubMed ID: 21555606
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Safety of Rituximab in Granulomatosis With Polyangiitis and in Microscopic Polyangiitis.
Merkel PA; Niles JL; Mertz LE; Lehane PB; Pordeli P; Erblang F
Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1372-1378. PubMed ID: 32475029
[TBL] [Abstract][Full Text] [Related]
9. [THE MECHANISMS OF ACTION OF RITUXIMAB].
Gil'deeva GN; Kudlai DA; Luk'yanov SV
Eksp Klin Farmakol; 2015; 78(12):51-6. PubMed ID: 27051930
[TBL] [Abstract][Full Text] [Related]
10. A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea.
Jo JC; Jeon Y; Kim D; Yang DH; Lee WS; Choi YS; Yi JH; Yoon DH; Kong JH; Choe JY; Kim S; Ahn K; Park T; Ju H; Kwon S; Cho SG
Expert Opin Biol Ther; 2023; 23(8):737-747. PubMed ID: 36757373
[TBL] [Abstract][Full Text] [Related]
11. Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis.
Borie D; Kremer JM
Semin Arthritis Rheum; 2015 Oct; 45(2):163-6. PubMed ID: 26190565
[TBL] [Abstract][Full Text] [Related]
12. Update on maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
Singer O; McCune WJ
Curr Opin Rheumatol; 2017 May; 29(3):248-253. PubMed ID: 28306595
[TBL] [Abstract][Full Text] [Related]
13. Progressive multifocal leukoencephalopathy and rheumatoid arthritis treatments.
Clavel G; Moulignier A; Semerano L
Joint Bone Spine; 2017 Dec; 84(6):671-675. PubMed ID: 28323224
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal encephalopathy after cyclophosphamide in granulomatosis with polyangiitis (Wegener) patients: case report and review of literature.
Pugnet G; Pagnoux C; Bézanahary H; Ly KH; Vidal E; Guillevin L
Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S62-4. PubMed ID: 23663683
[TBL] [Abstract][Full Text] [Related]
15. Pharmacovigilance and PML in the oncology setting.
Bennett CL
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S13-7. PubMed ID: 22123927
[TBL] [Abstract][Full Text] [Related]
16. Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
Sada KE; Yamamura M; Harigai M; Fujii T; Takasaki Y; Amano K; Fujimoto S; Muso E; Murakawa Y; Arimura Y; Makino H;
Arthritis Res Ther; 2015 Nov; 17():305. PubMed ID: 26525413
[TBL] [Abstract][Full Text] [Related]
17. [Recommendations on the use of rituximab for ANCA-associated vasculitis].
Gause AM; Rubbert-Roth A;
Z Rheumatol; 2014 Apr; 73(3):287-9. PubMed ID: 27039911
[TBL] [Abstract][Full Text] [Related]
18. Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis.
Iudici M; Quartier P; Terrier B; Mouthon L; Guillevin L; Puéchal X
Orphanet J Rare Dis; 2016 Oct; 11(1):141. PubMed ID: 27770813
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.
Carson KR; Evens AM; Richey EA; Habermann TM; Focosi D; Seymour JF; Laubach J; Bawn SD; Gordon LI; Winter JN; Furman RR; Vose JM; Zelenetz AD; Mamtani R; Raisch DW; Dorshimer GW; Rosen ST; Muro K; Gottardi-Littell NR; Talley RL; Sartor O; Green D; Major EO; Bennett CL
Blood; 2009 May; 113(20):4834-40. PubMed ID: 19264918
[TBL] [Abstract][Full Text] [Related]
20. Rituximab induction and reinduction in granulomatosis with polyangiitis and microscopic polyangiitis: A retrospective multicenter study in Taiwan.
Hsieh TY; Chen MH; Wu CC; Hong WJ; Lu CH; Lu CC; Lu LY; Hsieh SC; Tsai CY; Wu CS;
Int J Rheum Dis; 2023 Dec; 26(12):2441-2449. PubMed ID: 37784228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]